Published October, 2012
By Roderick J. Flower, N.J. Goulding, R.J. Flower, Roderick Flower and Nicolas Goulding
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

Following 50 years of glucocorticoid use in a clinical setting, an international body of expert scientists and physicians presents the most expansive survey of glucocorticoid pharmacology to date.

---

Published October, 2012
By Erik De Clercq and Anne-Mieke Vandamme
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

An extensive assessment of combination therapy of AIDS. Main focus is put on the Highly Active Antiretroviral Therapy (HAART) but other therapies like salvage therapy are also discussed. The chapters cover efficacy, treatment, causes of treatment failure, clinical care, guidelines, pharmacology.

---

Published October, 2012
By Jerry J. Buccafusco
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

During the past decade research into the pharmacology of cognition, particularly regarding learning and memory, has supported the concept that many potential neural targets exist for the development of cognitive-enhancing drugs.

---

Published October, 2012
By W. Schönfeld, H.A. Kirst and W. Schoenfeld
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

The following group of chapters cover the complex chemistry of the macro lactone structures, giving historic background, basic structure-activity relation ships of various derivatization strategies, and perspectives for future discovery of new semisynthetic macrolide antibiotics.

---

Published October, 2012
By Brian E. Leonard and Brian Leonard
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

Important clinical issues as the outcome of long term treatment with antidepressants, the time of onset of the antidepressant response and the limitations of the antidepressants currently available are covered in this monograph.

---

Published October, 2012
By P. Buckel
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products.

---

Published October, 2012
By Wolfgang Loscher and Wolfgang Loescher
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

In this volume on valproate emphasis is placed on the scientific back ground leading to the discovery of val pro ate, its subsequent pharmacologi cal and toxicological characterization, and its clinical development into one of the most widely and successfully used anti epileptic drugs, a real mile stone in drug therapy.

---

Published September, 2012
By Pedro D'Orléans-Juste and G.E. Plante
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

---

Published July, 2012
By Yuti Chernajovsky and Paul D. Robbins
Publisher: Springer (Springer Basel)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

In this monograph about gene therapy of autoimmune and inflammatory d- orders we have gathered international experts and leaders from different fields to review the state of the art advances on topics ranging from disease entities to vectors and engineered cells.

---

Published January, 2012
By Maryann Foote, Graham Molineux, Tara L. Arvedson and Tara Arvedson
Publisher: Springer (Springer Basel)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use.

---